The IBD medical home: a holistic approach to specialty care

November 9, 2017
The “patient-centered medical home” health care model presents a new way of coordinating patient care, focusing on the needs of the whole…
In the Journals

IBD patients on thiopurines, anti-TNFs show ‘small but significant’ lymphoma risk

November 7, 2017
Patients with inflammatory bowel disease who used thiopurines or anti-tumor necrosis factor agents showed a “small but statistically…
In the Journals

Cigarette smoking triggers intestinal inflammation, may cause IBD

November 1, 2017
A new preclinical study published in Frontiers in Immunology showed that exposing mice to cigarette smoke resulted in colitis, and that this was…
Meeting NewsVideo

VIDEO: Personalized IBD treatment can enable proactive care

October 25, 2017
ORLANDO — In this exclusive video from the World Congress of Gastroenterology at ACG 2017, Corey A. Siegel, MD, MS, associate professor of…
In the Journals

MR enterography accurately diagnoses active inflammation in children with IBD

October 9, 2017
Magnetic resonance enterography showed high accuracy for diagnosing active inflammation in children with known or suspected inflammatory bowel…
In the Journals

IBD patients show better outcomes with proactive vs. reactive drug monitoring

October 5, 2017
Patients with inflammatory bowel disease showed better long-term clinical outcomes when they received proactive monitoring of Remicade serum levels…

Sherman Prize winner discusses integration, cooperation in IBD

October 4, 2017
In his long career as a gastroenterologist, Stephen R. Targan, MD, has seen many innovations and treatments emerge in his field.  But…

Microbiome therapy shows benefit in ulcerative colitis

October 2, 2017
SER-287, an oral microbiome treatment in development for inflammatory bowel disease, showed positive results in patients with ulcerative colitis in a…
In the Journals

Cancer risk doubled in childhood-onset IBD

September 25, 2017
Children with inflammatory bowel disease showed a twofold higher risk for developing cancer, especially GI cancer, and this risk persisted well into…

Janssen licenses two IBD drug candidates to new biopharma company

September 22, 2017
Provention Bio, a new clinical stage biopharmaceutical company launched earlier this year, announced it has in-licensed two clinical-stage…
Advertisement
Advertisement